NCT00194493 |
|
Computerized Assessment for Patients With Cancer
|
View
|
NCT00194480 |
|
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
|
View
|
NCT00194467 |
|
Suppression of Oral HHV8 Shedding With Valganciclovir
|
View
|
NCT00194454 |
|
PsychosocialBehavioral Intervention in Post-Stroke Depression
|
View
|
NCT00194441 |
|
Cerebral Perfusion Pressure CPP Management Information Feedback and Nursing
|
View
|
NCT00194428 |
|
Weight and Metabolic Effects of an Almond Enriched Hypocaloric Low Fat Diet on Overweight and Obese Persons
|
View
|
NCT00194415 |
|
A Study of HSV Testing Among Pregnant Women
|
View
|
NCT00194402 |
|
SLIM Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
|
View
|
NCT00194376 |
|
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
|
View
|
NCT00194363 |
|
Strength Training Intervention for Breast Cancer Survivors and the Effects on Lymphedema Status
|
View
|
NCT00194350 |
|
Factor V Leiden Mutation and Implantation Failure
|
View
|
NCT00194324 |
|
Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina
|
View
|
NCT00194311 |
|
Human Papillomavirus HPV Infection in Pregnancy
|
View
|
NCT00194298 |
|
FDG-PET Imaging in Complicated Diabetic Foot
|
View
|
NCT00194285 |
|
FDG-PET Imaging in Painful Joint Prosthesis
|
View
|
NCT00194272 |
|
Two-Dose Methotrexate for Ectopic Pregnancy
|
View
|
NCT00194259 |
|
Sleep Apnea in Look AHEAD Action for Health in Diabetes
|
View
|
NCT00194246 |
|
Cognitive Function and Cue-Reactivity Study
|
View
|
NCT00194233 |
|
Serum and Peritoneal Fluid Bank for Endometriosis Markers
|
View
|
NCT00194220 |
|
Infertility Markers in Serum Urine and Follicular Fluid
|
View
|
NCT00194207 |
|
Risk Factors of Ectopic Pregnancy
|
View
|
NCT00194194 |
|
Healthetech Inc SMART Study
|
View
|
NCT00194181 |
|
Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath
|
View
|
NCT00194168 |
|
Ectopic Pregnancy Biomarkers
|
View
|
NCT00194155 |
|
Cytomegalovirus CMV Infection in Pregnancy
|
View
|
NCT00194142 |
|
Cytomegalovirus CMV Infection in Amniotic Fluid
|
View
|
NCT00194129 |
|
Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
|
View
|
NCT00194116 |
|
Double-blind Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
|
View
|
NCT00194103 |
|
Effectiveness of Extended Telephone Monitoring
|
View
|
NCT00194090 |
|
Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk
|
View
|
NCT00194077 |
|
Study of Aripiprazole Abilify in Children With Symptoms of Mania
|
View
|
NCT00194064 |
|
Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
|
View
|
NCT00194051 |
|
Symptomatic Biomechanical and Radiographic Outcomes in Knee Osteoarthritis Following Gastric Bypass Surgery
|
View
|
NCT00194038 |
|
Aripiprazole in Late Life Bipolar Disorder
|
View
|
NCT00194025 |
|
Valproate in Late Life Schizophrenia
|
View
|
NCT00194012 |
|
Study of Aripiprazole Abilify Versus Placebo in Children With Subsyndromal Bipolar Disorder
|
View
|
NCT00193999 |
|
Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting
|
View
|
NCT00193986 |
|
Assessment of Prepulse Inhibition for Shock Pain Reduction
|
View
|
NCT00193973 |
|
Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
|
View
|
NCT00193960 |
|
The Results of Ahmed Valve Operations
|
View
|
NCT00193947 |
|
An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy
|
View
|
NCT00193934 |
|
Magnetic Resonance Imaging MRI Staging of Cervix Cancer
|
View
|
NCT00193921 |
|
Chemoradiotherapy in Patients With Localised Lung Cancer
|
View
|
NCT00193908 |
|
Cavilon Breast Trial Comparison of Cavilon Durable Barrier Cream to Glycerine Sorbolene Cream
|
View
|
NCT00193895 |
|
Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck
|
View
|
NCT00193882 |
|
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia
|
View
|
NCT00193869 |
|
SuperDEX Trial Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy
|
View
|
NCT00193856 |
|
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
|
View
|
NCT00193843 |
|
Oral Cancer Adjuvant Therapy OCAT Trial
|
View
|
NCT00193830 |
|
High Dose Rate HDR Versus Low Dose Rate LDR Brachytherapy in Carcinoma Cervix
|
View
|
NCT00193817 |
|
Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial
|
View
|
NCT00193804 |
|
A Trial Comparing Intensity Modulated Radiation Therapy IMRT With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix
|
View
|
NCT00193791 |
|
Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix
|
View
|
NCT00193778 |
|
Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation
|
View
|
NCT00193765 |
|
Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity
|
View
|
NCT00193752 |
|
Para-Aortic Lymph Nodal Staging Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix
|
View
|
NCT00193739 |
|
Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix
|
View
|
NCT00193726 |
|
Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer
|
View
|
NCT00193713 |
|
Bifeprunox in the Treatment of Schizophrenia
|
View
|
NCT00193700 |
|
Pharmacokinetic Evaluation of Testosterone Gel 1
|
View
|
NCT00193687 |
|
Bifeprunox in the Treatment of Schizophrenia
|
View
|
NCT00193674 |
|
Habitual Abortion Study Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
|
View
|
NCT00193661 |
|
Observation Study of T-Gel 1 in Treatment of Adolescent Boys With Hypogonadism
|
View
|
NCT00193648 |
|
Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis FSGS
|
View
|
NCT00193635 |
|
Pilot Study of Mycophenolate Mofetil in Congenital Uropathies
|
View
|
NCT00193622 |
|
Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
|
View
|
NCT00193609 |
|
Oxaliplatin and Capecitabine in the Treatment of RelapsedRefractory Carcinoma of Unknown Primary Site
|
View
|
NCT00193596 |
|
GemcitabineIrinotecanZD1839 vs PaclitaxelCarboplatinEtoposideZD1839 in Carcinoma of Unknown Primary Site
|
View
|
NCT00193583 |
|
Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory andor Advanced Solid Tumors
|
View
|
NCT00193570 |
|
Topotecan in Combination With Docetaxel in Refractory andor Advanced Solid Tumors
|
View
|
NCT00193557 |
|
Weekly Bortezomib Velcade in the Treatment of Patients With Refractory Multiple Myeloma
|
View
|
NCT00193544 |
|
Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma
|
View
|
NCT00193531 |
|
Paclitaxel Carboplatin and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
|
View
|
NCT00193518 |
|
Arsenic Trioxide in RelapsedRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
|
View
|
NCT00193505 |
|
IfosfamideCarboplatinEtoposideRituxan Followed by Zevalin in RelapsedRefractory Intermediate Grade B-Cell Lymphoma
|
View
|
NCT00193492 |
|
A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkins Lymphoma
|
View
|
NCT00193479 |
|
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab in Large B-Cell Non-Hodgkins Lymphoma
|
View
|
NCT00193466 |
|
Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
|
View
|
NCT00193453 |
|
Gemcitabine Docetaxel and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
|
View
|
NCT00193440 |
|
Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkins Lymphoma
|
View
|
NCT00193427 |
|
Preoperative Therapy in Patients With Stages IB II IIIA and Selected IIIB Patients With Non-Small Cell Lung Cancer
|
View
|
NCT00193414 |
|
Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
|
View
|
NCT00193401 |
|
Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
|
View
|
NCT00193388 |
|
Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer
|
View
|
NCT00193375 |
|
Irinotecan Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
|
View
|
NCT00193362 |
|
Study of Paclitaxel Carboplatin and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
|
View
|
NCT00193349 |
|
Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer
|
View
|
NCT00193336 |
|
Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer
|
View
|
NCT00193323 |
|
Weekly Docetaxel Versus Weekly DocetaxelGemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
|
View
|
NCT00193310 |
|
Preoperative or Postoperative Therapy of Patients With Stages IB II IIIA Non-Small Cell Lung Cancer
|
View
|
NCT00193297 |
|
Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
|
View
|
NCT00193284 |
|
Chemotherapy Plus Gefitinib Followed by Chemotherapy Radiation Therapy and Gefitinib For Head and Neck Cancer
|
View
|
NCT00193271 |
|
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
|
View
|
NCT00193258 |
|
Bevacizumab Erlotinib and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
|
View
|
NCT00193245 |
|
Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
|
View
|
NCT00193232 |
|
Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
|
View
|
NCT00193219 |
|
Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
|
View
|
NCT00193206 |
|
Neo-adjuvant Gemcitabine Epirubicin ABI-007 GEA in Locally Advanced or Inflammatory Breast Cancer
|
View
|
NCT00193193 |
|
Weekly Paclitaxel Low-Dose Estramustine and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma
|
View
|
NCT00193180 |
|
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
|
View
|
NCT00193167 |
|
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer
|
View
|
NCT00193154 |
|
OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma
|
View
|
NCT00193141 |
|
Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer
|
View
|
NCT00193128 |
|
Preoperative Therapy With OxaliplatinDocetaxelCapecitabine and Radiation in Resectable Esophagus Cancer
|
View
|
NCT00193115 |
|
Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
|
View
|
NCT00193102 |
|
Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer
|
View
|
NCT00193089 |
|
Docetaxel Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
|
View
|
NCT00193076 |
|
Combination Gemcitabine Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
|
View
|
NCT00193063 |
|
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 HER2 Positive Metastatic Breast Cancer
|
View
|
NCT00193050 |
|
Weekly Gemcitabine Epirubicin and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
|
View
|
NCT00193037 |
|
Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
|
View
|
NCT00193024 |
|
Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
|
View
|
NCT00193011 |
|
Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer
|
View
|
NCT00192998 |
|
The Serotonergic Transmitter System in Dementia and Affective Disorders
|
View
|
NCT00192985 |
|
Does a Nitrofurazone Coated Bladder Catheter Reduce the Number of Urinary Tract Infections in Trauma
|
View
|
NCT00192972 |
|
A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation
|
View
|
NCT00192959 |
|
Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects
|
View
|
NCT00192946 |
|
The CRT-KIR Study Cardiac Resynchronization Therapy CRT in the Early Phase After Heart Surgery
|
View
|
NCT00192933 |
|
Evaluation of the Quality of the NovoSeven rFVIIa Tratment Practice at Rigshospitalet Copenhagen University Hospital
|
View
|
NCT00192920 |
|
Evaluation of the Quality of the Transfusion Practice at Rigshospitalet Copenhagen University Hospital
|
View
|
NCT00192907 |
|
Inflammation and Infection in Trauma Role in Posttraumatic Complications
|
View
|
NCT00192894 |
|
New Methods to Detect a Decrease in Heart Function
|
View
|
NCT00192881 |
|
Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease
|
View
|
NCT00192868 |
|
Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction
|
View
|
NCT00192855 |
|
Entacapone Augmentation for Schizophrenia
|
View
|
NCT00192842 |
|
Gemcitabine With Curcumin for Pancreatic Cancer
|
View
|
NCT00192829 |
|
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
|
View
|
NCT00192816 |
|
Pain Perception in Alzheimers Disease
|
View
|
NCT00192803 |
|
Non-Insulin Dependent Diabetes Mellitus NIDDM and Angiotensin Converting Enzyme 2 ACE2 Diabetic Patients Treated With Antihypertensive Drugs
|
View
|
NCT00192790 |
|
Pain Perception is Attenuated in Patients With Painless Myocardial Infarction
|
View
|
NCT00192777 |
|
Concurrent Xeloda and Radiotherapy for Bone Metastases
|
View
|
NCT00192764 |
|
High Dose CHOP in Lymphoma
|
View
|
NCT00192751 |
|
From Compliance to Alliance Engaging Psychiatric Patients in Illness Management
|
View
|
NCT00192738 |
|
Does Telephone Follow-up Improve Patients Satisfaction
|
View
|
NCT00192725 |
|
Tryptophan Depletion in Acute Mania
|
View
|
NCT00192712 |
|
Irinotecan Gemcitabine and Radiation Therapy for Pancreatic Cancer
|
View
|
NCT00192699 |
|
Bimetric-10 Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric Stem
|
View
|
NCT00192686 |
|
Cultures amKamme-Lindbergh in Suspicion of Infected TKA
|
View
|
NCT00192673 |
|
PolyEthylene GlycolPEG-Asparaginase During Two Treatment Courses
|
View
|
NCT00192660 |
|
HIV Infection And Metabolic Abnormalities Protocol 1 HAMA001
|
View
|
NCT00192647 |
|
A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C CHC Genotype 1 Infection
|
View
|
NCT00192634 |
|
A Randomised Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine The STEAL Study
|
View
|
NCT00192621 |
|
Seronegatives and Metabolic Abnormalities Protocol 2 SAMA002 Study to Compare the Effect of Kaletra and Combivir in HIV-Negative Healthy Subjects
|
View
|
NCT00192608 |
|
A 48-Week Randomised Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation the ASK-500 Study
|
View
|
NCT00192595 |
|
Tenofovir in HIVHBV Coinfection
|
View
|
NCT00192582 |
|
AIMHI NT Relapse Prevention Trial
|
View
|
NCT00192569 |
|
Australian Trial in Acute Hepatitis C
|
View
|
NCT00192556 |
|
Food Incentives for TB Treatment Compliance in East Timor FITTCET
|
View
|
NCT00192543 |
|
The Fish and Fruit Study Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease
|
View
|
NCT00192517 |
|
Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
|
View
|
NCT00192504 |
|
Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus RSV in Children Hospitalized With RSV Infection
|
View
|
NCT00192491 |
|
Trial to Assess Safety Tolerability and Immunogenicity of Influenza Virus Vaccine Trivalent Types A B Live Cold-Adapted FluMist and Measles Mumps Rubella and Varicella Vaccines Administered Concurrently to Healthy Children
|
View
|
NCT00192478 |
|
Open-Label Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mgkg or 15 mgkg Children to be Followed for 90 Days After Their Last Dose of MEDI-524
|
View
|
NCT00192465 |
|
Trial to Evaluate the Safety Tolerability and Pharmacokinetics of MEDI-524 in Healthy Adults
|
View
|
NCT00192452 |
|
Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis
|
View
|
NCT00192439 |
|
Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk
|
View
|
NCT00192426 |
|
Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children
|
View
|
NCT00192413 |
|
Trial to Compare the Safety Tolerability and Efficacy of Influenza Virus Vaccine CAIV-T With Inactivated Influenza Vaccine Trivalent Types A B in Adults Aged 60 Years and Older Against Culture-confirmed Influenza
|
View
|
NCT00192400 |
|
Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children
|
View
|
NCT00192387 |
|
Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid CAIV-T
|
View
|
NCT00192374 |
|
Trial to Compare the Safety Tolerability Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine CAIV-T in Healthy Children
|
View
|
NCT00192361 |
|
Trial of the Safety Transmissibility and Phenotypic and Genotypic Stability of Influenza Virus VaccineCAIV-T in Children Who Attend Day Care Final Report Version 20
|
View
|
NCT00192348 |
|
A Prospective Randomized Double-Blind Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus VaccineCAIV-T in Healthy Infants
|
View
|
NCT00192335 |
|
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants
|
View
|
NCT00192322 |
|
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine CAIV-T in Healthy Children
|
View
|
NCT00192309 |
|
Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine
|
View
|
NCT00192296 |
|
Study to Evaluate the Safety TolerabilityImmunogenicity and Pharmacokinetics of MEDI-528 in Healthy Adult Volunteers
|
View
|
NCT00192283 |
|
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine Trivalent Types A B Live Cold- Adapted CAIV-T in Healthy Children Attending Day Care Centers
|
View
|
NCT00192270 |
|
Trial to Assess Safety Tolerability and Immunogenicity of Influenza Virus Vaccine Trivalent Types A and B Live Cold-adapted CAIV-T in Healthy Children
|
View
|
NCT00192257 |
|
Trial to Compare the Safety Tolerability and Efficacy of Influenza Virus Vaccine CAIV-T With Influenza Virus in Children With Asthma
|
View
|
NCT00192244 |
|
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine Trivalent Types A B Live Cold-Adapted CAIV-T in Healthy Children
|
View
|
NCT00192231 |
|
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus VaccineCAIV-T
|
View
|
NCT00192218 |
|
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
|
View
|
NCT00192205 |
|
Trial to Compare the SafetyTolerability and Efficacy of Influenza Virus Vaccine CAIV-T With Influenza Virus Vaccine Trivalent Inactivated TIV in Children
|
View
|
NCT00192192 |
|
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine Trivalent Types A B Live Cold Adapted CAIV-T in Healthy Adults
|
View
|
NCT00192179 |
|
A Phase II Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years
|
View
|
NCT00192166 |
|
Trial to Assess Safety Efficacy Tolerability and Immunogenicity of Influenza Virus Vaccine Liquid Formulation CAIV-T Administered Concomitantly With a Combination Live Attenuated Mumps Measles and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
|
View
|
NCT00192153 |
|
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus VaccineCAIV-Tin Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
|
View
|
NCT00192140 |
|
Trial to Assess the SheddingImmunogenicity and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
|
View
|
NCT00192127 |
|
Study to Evaluate the Safety of a Bivalent Vaccine of New 62 Influenza Virus Reassortants in Healthy Adults
|
View
|
NCT00192114 |
|
Enzastaurin for Patients With Metastatic Colorectal Cancer
|
View
|
NCT00192101 |
|
Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines andor Taxanes
|
View
|
NCT00192088 |
|
A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
|
View
|
NCT00192075 |
|
A Randomized Trial of Avastin Gemcitabine 5-Fluorouracil 5FUFolinic Acid Versus Avastin Oxaliplatin 5FUFolinic Acid in Metastatic Colorectal Cancer
|
View
|
NCT00192062 |
|
A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer
|
View
|
NCT00192049 |
|
A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer
|
View
|
NCT00192036 |
|
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer
|
View
|
NCT00192023 |
|
An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-DeficitHyperactivity Disorder ADHD and Comorbid Oppositional Defiant Disorder ODD
|
View
|
NCT00191997 |
|
Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
|
View
|
NCT00191984 |
|
A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
|
View
|
NCT00191971 |
|
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium TCC After CDDP Regimen
|
View
|
NCT00191945 |
|
Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-DeficitHyperactivity Disorder ADHD
|
View
|
NCT00191932 |
|
Switching to Duloxetine From Other Antidepressants
|
View
|
NCT00191919 |
|
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
|
View
|
NCT00191906 |
|
Comparison of Atomoxetine and Placebo in Children With Attention-DeficitHyperactivity Disorder ADHD andor Reading Disorder RD
|
View
|
NCT00191893 |
|
Bone Effects of Teriparatide Following Alendronate
|
View
|
NCT00191880 |
|
Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention DeficitHyperactivity Disorder
|
View
|
NCT00191867 |
|
Clinical Trial of Teriparatide in Japan
|
View
|
NCT00191854 |
|
Gemcitabine Combinations in Metastatic Breast Cancer MBC 1st Line
|
View
|
NCT00191841 |
|
Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy
|
View
|